tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Skye Bioscience Inc

SKYE
Add to Watchlist
1.780USD
+0.015+0.85%
Close 09-21 16:00（ET）
7.78MMarket Cap
LossP/E TTM

Skye Bioscience Inc

1.780
+0.015+0.85%
Overview
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

SKYE Financials

See Skye Bioscience Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
7.78M
Dividend TTM
0.00
P/E TTM
-1.23
EPS TTM
-1.45
Revenue
--
Net Profit
-26.57M
ROE
-167.97%
ROA
-136.16%

Skye Bioscience Inc Earnings Date

Latest Release
Aug 14, 2026
EPS / Forecast
-0.27/-0.25
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-389.17%-2.17
-12.58%-0.32
-478.58%-1.41
-220.21%-0.32
-117.45%-0.44
-56.20%-0.28
31.62%-0.24
96.83%-0.10
74.45%-0.20
86.94%-0.18
89.43%-0.36
---3.17
---0.80
---1.37
---3.37
---4.83
----
----
----
----
Net Profit
38.80%-10.79M
-12.66%-12.51M
-48.18%-14.44M
-227.19%-12.75M
-123.02%-17.62M
-121.20%-11.10M
-120.51%-9.75M
84.37%-3.90M
-153.99%-7.90M
2.86%-5.02M
55.32%-4.42M
-697.68%-24.95M
9.00%-3.11M
-69.79%-5.17M
-293.65%-9.89M
-71.38%-3.13M
-68.93%-3.42M
-40.86%-3.04M
-67.29%-2.51M
-40.73%-1.82M
Debt to assets ratio
--1.30%
--1.29%
----
----
----
----
-100.00%0.00%
-100.00%0.00%
37.41%5.57%
40.59%4.86%
80.48%36.62%
--26.71%
--4.05%
--3.46%
--20.29%
--85.59%
----
----
----
----
Income Statement
Operating profit
57.18%-7.81M
-7.78%-12.67M
-20.64%-14.90M
-39.30%-13.26M
-117.05%-18.24M
-91.14%-11.76M
-202.17%-12.35M
61.46%-9.52M
-180.67%-8.41M
-98.45%-6.15M
-32.77%-4.09M
-745.43%-24.71M
6.95%-2.99M
-7.35%-3.10M
-25.03%-3.08M
-60.64%-2.92M
-75.90%-3.22M
-66.24%-2.89M
-86.64%-2.46M
-18.26%-1.82M
Net Profit
38.80%-10.79M
-12.66%-12.51M
-48.18%-14.44M
-227.19%-12.75M
-123.02%-17.62M
-121.20%-11.10M
-120.51%-9.75M
84.37%-3.90M
-153.99%-7.90M
2.86%-5.02M
55.32%-4.42M
-697.68%-24.95M
9.00%-3.11M
-69.79%-5.17M
-293.65%-9.89M
-71.38%-3.13M
-68.93%-3.42M
-40.86%-3.04M
-67.29%-2.51M
-40.73%-1.82M
Balance Sheet
Current assets
-78.33%10.96M
-70.54%18.57M
-61.75%27.09M
-49.97%39.92M
-41.86%50.58M
-33.35%63.03M
507.92%70.83M
422.09%79.81M
4496.88%87.00M
2024.75%94.57M
30.27%11.65M
469.68%15.29M
-60.35%1.89M
-36.35%4.45M
-6.95%8.94M
-76.53%2.68M
-12.70%4.77M
29.94%6.99M
260.76%9.61M
162.93%11.43M
Total current liabilities
38.73%11.53M
95.60%10.40M
89.11%8.21M
48.78%8.37M
-41.97%8.31M
-66.33%5.32M
-68.79%4.34M
-59.00%5.62M
45.90%14.32M
68.68%15.80M
14.70%13.90M
123.23%13.72M
87.45%9.82M
124.01%9.37M
209.78%12.12M
309.28%6.15M
238.27%5.24M
202.08%4.18M
396.98%3.91M
24.00%1.50M
Total assets
-78.85%11.03M
-70.03%19.42M
-61.09%28.31M
-49.32%41.32M
-40.22%52.16M
-31.68%64.79M
509.39%72.76M
422.52%81.54M
3802.67%87.26M
1967.51%94.84M
31.05%11.94M
443.93%15.60M
-54.99%2.24M
-36.39%4.59M
-7.55%9.11M
-75.45%2.87M
-9.49%4.97M
33.56%7.21M
268.87%9.86M
168.69%11.69M
Total liabilities
35.91%11.53M
87.72%10.40M
79.73%8.29M
48.08%8.49M
-41.30%8.48M
-65.25%5.54M
-67.23%4.61M
-58.79%5.73M
44.16%14.45M
70.29%15.95M
16.12%14.07M
126.02%13.91M
90.26%10.03M
121.06%9.37M
203.67%12.12M
79.81%6.15M
63.80%5.27M
45.12%4.24M
79.70%3.99M
37.10%3.42M
Total equity
-101.14%-497.31K
-84.79%9.01M
-70.62%20.02M
-56.68%32.84M
-40.01%43.68M
-24.89%59.25M
3296.88%68.15M
4371.49%75.80M
1034.74%72.81M
1750.08%78.88M
29.13%-2.13M
151.61%1.70M
-2480.73%-7.79M
-260.79%-4.78M
-151.30%-3.01M
-139.75%-3.28M
-113.29%-301.82K
19.95%2.97M
1200.88%5.86M
345.93%8.26M
Cash Flow Statement
Net operating income
33.73%-7.12M
6.83%-8.56M
-19.50%-9.77M
-153.94%-13.36M
-51.49%-10.75M
-95.10%-9.19M
-112.58%-8.17M
-29.79%-5.26M
-256.13%-7.09M
-15.94%-4.71M
21.08%-3.84M
-97.16%-4.05M
31.34%-1.99M
-39.32%-4.06M
-147.43%-4.87M
-38.35%-2.06M
-73.57%-2.90M
-116.22%-2.91M
-10.24%-1.97M
24.70%-1.49M
Net investment
160.24%7.14M
185.07%10.90M
-3200.88%-2.80M
651.16%7.97M
-36418.58%-11.86M
-1221.66%-12.81M
1388.44%90.41K
-234.71%-1.45M
---32.46K
-79.35%1.14M
-100.12%-7.02K
393.13%1.07M
100.00%0.00
276758.63%5.53M
10586.15%5.67M
-1273.20%-366.07K
-16077.76%-84.04K
81.31%-2.00K
-647.41%-54.04K
---26.66K
Net financing
-656.31%-101.01K
---71.53K
103.15%11.41K
--0.00
100.87%18.16K
-100.00%0.00
124.80%5.62K
-100.00%0.00
-1598.41%-2.10M
189149.41%85.65M
-166.32%-22.65K
18211.45%16.63M
-34.37%-123.41K
23.55%-45.31K
140.80%34.16K
-101.24%-91.85K
-105.39%-91.85K
-101.47%-59.26K
-320.32%-83.72K
21.66%7.42M

FAQs

What are the current assets of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its current assets were 27.09M, with a year-on-year change of -61.75.

What are the total assets of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its total assets of Skye Bioscience Inc were 28.31M, with a year-on-year change of -61.09.

What are the total liabilities of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its total liabilities of Skye Bioscience Inc were 8.29M, with a year-on-year change of 79.73.

What is the total equity of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its total equity of Skye Bioscience Inc was 20.02M, with a year-on-year change of -70.62.

What is the net operating income of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net operating income of Skye Bioscience Inc was -58.16M, with a year-on-year change of -59.67.

What is the net investment of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net investment of Skye Bioscience Inc was -19.50M, with a year-on-year change of -7839.37.

What is the net financing of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net financing of Skye Bioscience Inc was 29.57K, with a year-on-year change of -99.96.

What is the Earnings Per Share (EPS) of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -11.28, with a year-on-year change of -1449.16.

What is the net income of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net income was -55.92M, with a year-on-year change of -110.50.

What is the Return on Equity (ROE) of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its Return on Equity (ROE) was -126.85, with a year-on-year change of -57.61.

What is the Return on Assets (ROA) of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its Return on Assets (ROA) was -110.66, with a year-on-year change of -76.40.

What is the operating profit of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its operating profit was -58.16M, with a year-on-year change of -59.67.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy